Literature DB >> 9893708

Growth hormone-releasing peptide (GHRP).

C Y Bowers1.   

Abstract

Growth hormone-releasing peptides and non-peptides (GHRPs. GHRP-GHS) are a new chemical class of GH secretagogues with a chemistry that ranges from small synthetic peptides to peptidomimetics. They release GH in animals and humans by a unique dual and complementary action on the hypothalamus and pituitary. Although the present GHRPs are of unnatural origin, evidence by a number of investigators is gradually accumulating to support that GHRP reflects the GH-releasing action of a new natural hypothalamic hormone yet to be isolated and identified. Despite the de novo origin of GHRP, a major reason for the persistent investigation is because of the possible practical diagnostic and therapeutic value in humans as well as the potential theoretical value of new insight into the physiological regulation of GH secretion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9893708     DOI: 10.1007/s000180050257

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  20 in total

1.  Reflections on growth hormone.

Authors:  R Deghenghi
Journal:  J Endocrinol Invest       Date:  2000 Jul-Aug       Impact factor: 4.256

2.  GHRP-6 is able to stimulate cortisol and ACTH release in patients with Cushing's disease: comparison with DDAVP.

Authors:  J H A Oliveira; J G H Vieira; J Abucham; A M J Lengyel
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256

Review 3.  Ghrelin: a new player in the control of gastrointestinal functions.

Authors:  T L Peeters
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

Review 4.  The Safety and Efficacy of Growth Hormone Secretagogues.

Authors:  John T Sigalos; Alexander W Pastuszak
Journal:  Sex Med Rev       Date:  2017-04-08

5.  Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.

Authors:  C Y Bowers; R Granda-Ayala
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

Review 6.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

Review 7.  ISSN exercise & sports nutrition review update: research & recommendations.

Authors:  Chad M Kerksick; Colin D Wilborn; Michael D Roberts; Abbie Smith-Ryan; Susan M Kleiner; Ralf Jäger; Rick Collins; Mathew Cooke; Jaci N Davis; Elfego Galvan; Mike Greenwood; Lonnie M Lowery; Robert Wildman; Jose Antonio; Richard B Kreider
Journal:  J Int Soc Sports Nutr       Date:  2018-08-01       Impact factor: 5.150

8.  Ghrelin-Induced Enhancement of Vasopressin and Oxytocin Secretion in Rat Neurohypophyseal Cell Cultures.

Authors:  M Gálfi; M Radács; Zs Molnár; I Budai; G Tóth; A Pósa; K Kupai; Z Szalai; R Szabó; H A Molnár; J Gardi; Ferenc A László; Cs Varga
Journal:  J Mol Neurosci       Date:  2016-10-17       Impact factor: 3.444

9.  Effect of ghrelin on glucose-insulin homeostasis: therapeutic implications.

Authors:  Susana Sangiao-Alvarellos; Fernando Cordido
Journal:  Int J Pept       Date:  2010-02-09

10.  Cognitive enhancing effects of ghrelin receptor agonists.

Authors:  Zeenat Atcha; Woei-Shin Chen; Agnes B Ong; Fong-Kuan Wong; Aveline Neo; Edward R Browne; Jason Witherington; Darrel J Pemberton
Journal:  Psychopharmacology (Berl)       Date:  2009-08-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.